Results
101
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
101 companies
Hypera
Market Cap: R$16.7b
Operates as a pharmaceutical company in Brazil.
HYPE3
R$26.42
7D
-2.2%
1Y
-6.9%
Selvita
Market Cap: zł583.7m
Operates as a contract research organization worldwide.
SLV
zł31.80
7D
11.6%
1Y
-52.0%
Green Thumb Industries
Market Cap: CA$1.8b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
GTII
CA$7.71
7D
-14.8%
1Y
-49.6%
Genovis AB (publ.)
Market Cap: SEK 1.8b
Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.
GENO
SEK 27.85
7D
-2.1%
1Y
-3.6%
Dong-A Socio Holdings
Market Cap: ₩781.9b
Engages in the pharmaceutical business in South Korea.
A000640
₩121,500.00
7D
0%
1Y
15.2%
Medy-Tox
Market Cap: ₩1.1t
Operates as a biopharmaceutical company in South Korea.
A086900
₩163,000.00
7D
-0.06%
1Y
-7.0%
Bruker
Market Cap: US$6.1b
Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally.
BRKR
US$40.55
7D
-7.4%
1Y
-34.5%
Medical Developments International
Market Cap: AU$73.8m
Manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally.
MVP
AU$0.66
7D
12.9%
1Y
33.7%
Boryung
Market Cap: ₩724.6b
Engages in the manufacture and sale of pharmaceutical products in South Korea and internationally.
A003850
₩8,630.00
7D
-0.1%
1Y
-18.4%
Solara Active Pharma Sciences
Market Cap: ₹32.7b
Manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India, Asia Pacific, Europe, North America, South America, and internationally.
SOLARA
₹678.70
7D
2.1%
1Y
23.9%
Nanjing Vazyme Biotech
Market Cap: CN¥9.6b
Offers technology solutions for life science, biomedicine, and in vitro diagnostics.
688105
CN¥24.11
7D
2.9%
1Y
18.2%
Knight Therapeutics
Market Cap: CA$602.7m
Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.
GUD
CA$6.05
7D
-1.3%
1Y
5.6%
Aroa Biosurgery
Market Cap: AU$200.1m
Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.
ARX
AU$0.58
7D
0.9%
1Y
-2.5%
Diaceutics
Market Cap: UK£108.6m
A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.
DXRX
UK£1.29
7D
8.0%
1Y
-3.4%
ECO Animal Health Group
Market Cap: UK£54.5m
Develops, registers, and markets pharmaceutical products for animals worldwide.
EAH
UK£0.81
7D
41.2%
1Y
-29.4%
Laurus Labs
Market Cap: ₹446.4b
Manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally.
LAURUSLABS
₹827.00
7D
4.7%
1Y
87.8%
AcrobiosystemsLtd
Market Cap: CN¥8.7b
Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and scientific research institutions.
301080
CN¥51.65
7D
4.0%
1Y
103.3%
Changchun BCHT Biotechnology
Market Cap: CN¥9.2b
Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines in China and internationally.
688276
CN¥22.32
7D
2.5%
1Y
-26.6%
Indoco Remedies
Market Cap: ₹29.8b
Manufactures, markets, and sells formulations and active pharmaceutical ingredients in India and internationally.
INDOCO
₹323.55
7D
-0.9%
1Y
-0.9%
Captor Therapeutics Spolka Akcyjna
Market Cap: zł228.3m
A biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases.
CTX
zł41.30
7D
9.5%
1Y
-47.1%
Swedencare
Market Cap: SEK 7.4b
Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.
SECARE
SEK 46.55
7D
1.2%
1Y
-7.2%
BrightGene Bio-Medical Technology
Market Cap: CN¥36.4b
A pharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products in China.
688166
CN¥86.29
7D
42.3%
1Y
184.4%
EZZ Life Science Holdings
Market Cap: AU$109.0m
Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally.
EZZ
AU$2.31
7D
5.0%
1Y
-1.7%
Hangzhou Bio-Sincerity Pharma-TechLtd
Market Cap: CN¥5.3b
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.
301096
CN¥48.64
7D
-1.2%
1Y
-3.3%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥44.6b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China.
688578
CN¥99.11
7D
4.5%
1Y
66.7%
Gan & Lee Pharmaceuticals
Market Cap: CN¥35.2b
A biopharmaceutical company, engages in the research, development, production, and sale of insulin analog active pharmaceutical ingredients (APIs) and injections in China.
603087
CN¥58.77
7D
5.2%
1Y
29.3%
Navamedic
Market Cap: NOK 436.3m
A pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally.
NAVA
NOK 24.70
7D
10.8%
1Y
-24.9%
Formycon
Market Cap: €524.4m
A biotechnology company, develops biosimilar drugs in Germany and Switzerland.
FYB
€29.70
7D
-0.8%
1Y
-42.3%
Nxera Pharma
Market Cap: JP¥77.0b
Develops and sells pharmaceutical products in Japan, the United States, Germany, Switzerland, Bermuda, and the United Kingdom.
4565
JP¥857.00
7D
-2.8%
1Y
-47.1%